Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy.

@article{Fleyfel1997RecombinantTT,
  title={Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy.},
  author={Maher Fleyfel and Karim Bourzoufi and G Huin and Damien Subtil and Francis Puech},
  journal={Canadian journal of anaesthesia = Journal canadien d'anesthesie},
  year={1997},
  volume={44 7},
  pages={735-8}
}
PURPOSE Prosthetic heart valve thrombosis occurring during pregnancy is a life-threatening complication. Surgical treatment requires clot removal under cardiopulmonary bypass (CPB) and carries a high mortality. We describe the successful use of thrombolytic therapy for recurrent thrombosed valve prosthesis in a pregnant patient. CLINICAL FEATURES A 32-yr-old patient whose pregnancy was complicated by two episodes of a thrombosed St Jude mitral prosthesis is reported. The first episode… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Therapeutic thrombolysis using recombinant tissue type plasminogen activator ( rtPA ) for a recurrent thrombosis of a tricuspid valve prosthesis during pregnan

  • C DiRoio, D Perrot, J Robin
  • Ann Fr Anesth Reanim
  • 1996

Therapeutic thrombolysis using recombinant tissue type plasminogen activator (rt-PA) for a recurrent thrombosis of a tricuspid valve prosthesis during pregnancy

  • JM, G M31lier, J Robin, MotinJ
  • Ann Fr Anesth Reanim
  • 1996

Similar Papers

Loading similar papers…